Results 11 to 20 of about 15,858 (169)

COVID-19 versus seasonal influenza: myocardial injury and prognostic importance

open access: yesBMC Infectious Diseases, 2022
Background Acute myocardial injury is associated with poor prognosis in respiratory tract infections. We aimed to highlight the differences in prevalence of myocardial injury and its impact on prognosis in patients with COVID-19 compared to those with ...
Lars Mizera   +7 more
doaj   +1 more source

Prevalence and predictors of difficult vascular anatomy in forearm artery access for coronary angiography and PCI

open access: yesScientific Reports, 2022
Transradial access has established as preferred access for cardiac catheterization. Difficult vascular anatomy (DVA) is a noticeable threat to procedural success.
Tobias Roeschl   +8 more
doaj   +1 more source

Where has pathophysiology gone in the era of evidence-based medicine? In Memoriam of Giuseppe Maria Andreozzi (1945-2026)

open access: yesVeins and Lymphatics
Professor Giuseppe Maria Andreozzi passed away on January 10, 2026. Born on October 13, 1945, he was a distinguished Italian physician and an internationally respected researcher in the field of Vascular Medicine.
Romeo Martini
doaj   +1 more source

Presence of contractile impairment appears crucial for structural remodeling in idiopathic left bundle-branch block

open access: yesJournal of Cardiovascular Magnetic Resonance, 2021
Background To differentiate effects of ventricular asynchrony from an underlying hypocontractile cardiomyopathy this study aimed to enhance the understanding of functional impairment and structural remodeling in idiopathic left bundle-branch block (LBBB).
Janek Salatzki   +13 more
doaj   +1 more source

Center Volumes Correlate with Likelihood of Stent Implantation in German Coronary Angiography

open access: yesJournal of Interventional Cardiology, 2023
Aims. Literature on percutaneous coronary intervention (PCI) stated an inverse relationship between hospital volume and mortality, but the effects on other characteristics are unclear. Methods.
Vera Oettinger   +7 more
doaj   +1 more source

The Benefits of Low-Carbohydrate, High-Fat (LCHF) Diet on Body Composition, Leg Volume, and Pain in Women with Lipedema

open access: yesJournal of Obesity, 2023
This study aimed to assess the potential benefits of a low-carbohydrate, high-fat (LCHF) diet on body composition, leg volume, and pain reduction in women with lipedema compared to overweight or women with obesity.
Małgorzata Jeziorek   +7 more
doaj   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller   +8 more
wiley   +1 more source

Predictors of the Efficacy of Lymphedema Decongestive Therapy

open access: yesMedicina
Lymphedema is a chronic condition characterized by the accumulation of lymphatic fluid in the tissues, causing swelling primarily in the limbs, though other body parts can also be affected.
Andrej Dzupina   +3 more
doaj   +1 more source

Pacemaker Lead Entanglement during Interventional PFO Occlusion: Salvage Using a Sizing Balloon

open access: yesCase Reports in Cardiology, 2023
We present a case of a patient with a transient ischaemic attack (TIA) likely due to paradoxical embolism through a patent foramen ovale (PFO). Her medical history included 2nd-degree heart block Mobitz II, which manifested with recurrent syncopes and ...
Andreas Goldschmied   +2 more
doaj   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy